...
首页> 外文期刊>Frontiers in Neuropharmacology >Serotonergic Modulation of Nigrostriatal and Mesolimbic Dopamine and Motor/Exploratory Behaviors in the Rat
【24h】

Serotonergic Modulation of Nigrostriatal and Mesolimbic Dopamine and Motor/Exploratory Behaviors in the Rat

机译:大鼠硝基睾丸和叶模莫氏多巴胺和电机/探索行为的Serotonergic调节

获取原文

摘要

The 5-HT2A receptor (R) is known to modulate dopamine (DA) release in the mammalian brain. Altanserin (ALT) and 2,5-dimethoxy-4-iodoamphetamine (DOI) act as 5-HT2AR antagonist and agonist, respectively. In the present study, we assessed the effects of ALT and DOI on motor and exploratory behaviors and on D2/3R binding in the rat brain with in vivo imaging methods. Methods: D2/3R binding was determined after systemic application of ALT (10 mg/kg) or DOI (0.5 mg/kg) and the respective vehicles [dimethyl sulfoxide (DMSO) and 0.9% saline (SAL)] with [123I]IBZM as a single-photon emission computed tomography (SPECT) radioligand. Anatomical information for the delineation of the target regions was obtained with dedicated small animal MRI. Immediately after 5-HT2AR antagonistic or agonistic treatment, motor/exploratory behaviors were assessed for 45 (ALT) or 30 min (DOI) in an open field. Additional rats underwent behavioral measurements after injection of DMSO or SAL. Results: ALT increased D2/3R binding in the ventral hippocampus relative to vehicle, while DOI augmented D2/3R binding in caudate putamen, frontal cortex, motor cortex, and ventral hippocampus. The 5-HT2AR agonist as well as antagonist decreased parameters of motor activity and active exploration. However, ALT, in contrast to DOI, decreased explorative head–shoulder motility and increased sitting. Conclusions: The regional increases of D2/3R binding after ALT and DOI (90 and 75 min post-challenge) may be conceived to reflect decreases of synaptic DA. The reductions of motor/exploratory activities (min 1–45 and min 1–30 after challenge with ALT and DOI, respectively) contrast the regional reductions of D2/3R binding, as they indicate elevated DA levels at the time of behavioral measurements. It may be concluded that ALT and DOI modulate DA in the individual regions of the nigrostriatal and mesolimbocortical pathways differentially and in a time-dependent fashion.
机译:已知5-HT2A受体(R)调节哺乳动物脑中的多巴胺(DA)释放。合成素(ALT)和2,5-二甲氧基-4-碘苯丙胺(DOI)分别充当5-HT2AR拮抗剂和激动剂。在本研究中,我们评估了ALT和DOI对电动机和探索性行为的影响以及在大鼠脑中的D2 / 3R与体内成像方法的结合。方法:用[123I] IBZM,在全身施用ALT(10mg / kg)或DOI(0.5mg / kg)和相应的车辆[二甲基亚砜(DMSO)和0.9%盐水(SAL)]后测定D2 / 3R结合。作为单光子发射计算断层扫描(SPECT)放射性配体。用专用的小动物MRI获得了拟法划清靶区域的解剖学信息。在5-HT2AR拮抗或激动治疗后,立即在开放场中评估45(ALT)或30分钟(DOI)的电动机/探索行为。额外的大鼠在注射DMSO或SAL后接受行为测量。结果:ALT相对于车辆在腹侧海马中的D2 / 3R结合增加,而DOI在尾部腐烂,额叶,电机皮质和腹侧海马中的D2 / 3R结合。 5-HT2AR激动剂以及拮抗剂降低的电机活动和主动探索。然而,与DOI相比,ALT减少了探索性的头部肩部运动和增加的坐姿。结论:可以构思ALT和DOI(90和75分钟)后的D2 / 3R结合的区域增加,以反映突触DA的减少。电动机/探索活动的减少(分别攻击ALT和DOI挑战后1-45和30分钟)对比D2 / 3R结合的区域减少,因为它们在行为测量时表示升高的DA水平。可以得出结论,Alt和Doi在尼格松和叶片内的各个区域中调节DA,差异依赖于依赖于时间的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号